Asif Zaman Rashid

Asif Zaman Rashid's AcademicInfluence.com Rankings

Asif Zaman Rashid

Philosophy

#9122

World Rank

#12632

Historical Rank

Logic

#6114

World Rank

#7597

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Asif Zaman Rashid's Degrees

Doctorate Medicine University of California, San Francisco
Masters Public Health University of California, Berkeley

Why Is Asif Zaman Rashid Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Asif Zaman Rashid's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. (2008) (3836)
Simplified staging for hepatocellular carcinoma. (2002) (667)
Efficacy of RAD001 (everolimus) and octreotide LAR in advanced low- to intermediate-grade neuroendocrine tumors: results of a phase II study. (2008) (631)
Histopathological identification of colon cancer with microsatellite instability. (2001) (501)
Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. Pathology Working Group Report. (2006) (440)
Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiation (2005) (410)
Mutation Profiling in Cholangiocarcinoma: Prognostic and Therapeutic Implications (2014) (336)
Progenitor/stem cells give rise to liver cancer due to aberrant TGF-β and IL-6 signaling (2008) (317)
Phase 2 study of erlotinib in patients with unresectable hepatocellular carcinoma (2007) (312)
Population-Based Study of Islet Cell Carcinoma (2007) (312)
Promoter methylation of E-cadherin gene in gastric mucosa associated with Helicobacter pylori infection and in gastric cancer (2003) (285)
Elevated expression of fatty acid synthase and fatty acid synthetic activity in colorectal neoplasia. (1997) (278)
Mylotarg™ (gemtuzumab ozogamicin) therapy is associated with hepatic venoocclusive disease in patients who have not received stem cell transplantation (2001) (264)
The effects of sulindac on colorectal proliferation and apoptosis in familial adenomatous polyposis. (1995) (263)
DNA methylation and environmental exposures in human hepatocellular carcinoma. (2002) (257)
CpG island methylation in aberrant crypt foci of the colorectum. (2002) (239)
Prediction of lung cancer using volatile biomarkers in breath. (2007) (238)
Phenotypic and molecular characteristics of hyperplastic polyposis. (2000) (235)
DNA methylation changes after 5-aza-2'-deoxycytidine therapy in patients with leukemia. (2006) (221)
Gallstones and the risk of biliary tract cancer: a population-based study in China (2007) (218)
Detection of lung cancer using weighted digital analysis of breath biomarkers. (2008) (216)
CpG island methylation in colorectal adenomas. (2001) (212)
Significance of the Depth of Tumor Invasion and Lymph Node Metastasis in Superficially Invasive (T1) Esophageal Adenocarcinoma (2005) (210)
Accumulated clonal genetic alterations in familial and sporadic colorectal carcinomas with widespread instability in microsatellite sequences. (1998) (207)
Mitochondrial proteins that regulate apoptosis and necrosis are induced in mouse fatty liver (1999) (206)
Histologic grading of the extent of residual carcinoma following neoadjuvant chemoradiation in pancreatic ductal adenocarcinoma (2012) (204)
PIK3CA/PTEN Mutations and Akt Activation As Markers of Sensitivity to Allosteric mTOR Inhibitors (2012) (198)
Development of biologic markers of response and assessment of antiangiogenic activity in a clinical trial of human recombinant endostatin. (2002) (193)
Concordant CpG island methylation in hyperplastic polyposis. (2002) (193)
Elevated expression of vascular endothelial growth factor correlates with increased angiogenesis and decreased progression‐free survival among patients with low‐grade neuroendocrine tumors (2007) (191)
Necrosis of the gastrointestinal tract in uremic patients as a result of sodium polystyrene sulfonate (Kayexalate) in sorbitol: an underrecognized condition. (1997) (190)
Upper Gastrointestinal Tract Injury in Patients Receiving Kayexalate (Sodium Polystyrene Sulfonate) in Sorbitol: Clinical, Endoscopic, and Histopathologic Findings (2001) (187)
Prognostic significance of CpG island methylator phenotype and microsatellite instability in gastric carcinoma. (2005) (182)
Dysplasia and dysregulation of proliferation in foveolar and surface epithelia of fundic gland polyps from patients with familial adenomatous polyposis. (1998) (182)
Gene expression profiling of localized esophageal carcinomas: association with pathologic response to preoperative chemoradiation. (2006) (174)
Eradication of Helicobacter pylori infection reverses E-cadherin promoter hypermethylation (2006) (172)
Frequent CpG island methylation in serrated adenomas of the colorectum. (2003) (171)
K-ras mutation, p53 overexpression, and microsatellite instability in biliary tract cancers: a population-based study in China. (2002) (158)
MicroRNA-196a is a potential marker of progression during Barrett's metaplasia-dysplasia-invasive adenocarcinoma sequence in esophagus. (2009) (148)
Perineural and Intraneural Invasion in Posttherapy Pancreaticoduodenectomy Specimens Predicts Poor Prognosis in Patients With Pancreatic Ductal Adenocarcinoma (2012) (146)
Inverse relationship between APC gene mutation in gastric adenomas and development of adenocarcinoma. (2002) (145)
CEBS—Chemical Effects in Biological Systems: a public data repository integrating study design and toxicity data with microarray and proteomics data (2007) (145)
Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas (2007) (144)
Hypomethylation of LINE-1 and Alu in well-differentiated neuroendocrine tumors (pancreatic endocrine tumors and carcinoid tumors) (2007) (143)
CpG island methylation in gastroenterologic neoplasia: a maturing field. (2004) (141)
CpG island methylation in carcinoid and pancreatic endocrine tumors (2003) (136)
Overexpression of receptor tyrosine kinase Axl promotes tumor cell invasion and survival in pancreatic ductal adenocarcinoma (2011) (134)
The number of lymph nodes with metastasis predicts survival in patients with esophageal or esophagogastric junction adenocarcinoma who receive preoperative chemoradiation (2006) (124)
Frequent CpG island methylation in precursor lesions and early gastric adenocarcinomas (2004) (120)
BRAF mutations in aberrant crypt foci and hyperplastic polyposis. (2005) (120)
Retrospective Study of Clinicopathologic Features and Prognosis of High-grade Neuroendocrine Carcinoma of the Esophagus (2008) (119)
Beyond BRAFV600: clinical mutation panel testing by next-generation sequencing in advanced melanoma (2014) (118)
Association of the CpG island methylator phenotype with family history of cancer in patients with colorectal cancer. (2003) (117)
Family history of gallstones and the risk of biliary tract cancer and gallstones: A population‐based study in Shanghai, China (2007) (111)
Mucinous and Nonmucinous Appendiceal Adenocarcinomas: Different Clinicopathological Features but Similar Genetic Alterations (2002) (110)
Epigenetic-Genetic Interactions in the APC/WNT, RAS/RAF, and P53 Pathways in Colorectal Carcinoma (2008) (107)
Genetic alterations in sporadic and Crohn's-associated adenocarcinomas of the small intestine. (1997) (107)
GSTP1 CpG island DNA hypermethylation in hepatocellular carcinomas. (2000) (106)
Excellent Interobserver Agreement on Grading the Extent of Residual Carcinoma After Preoperative Chemoradiation in Esophageal and Esophagogastric Junction Carcinoma: A Reliable Predictor for Patient Outcome (2007) (104)
Epigenetic alterations in neuroendocrine tumors: methylation of RAS-association domain family 1, isoform A and p16 genes are associated with metastasis (2005) (104)
Genetic Alterations in Goblet Cell Carcinoids of the Vermiform Appendix and Comparison with Gastrointestinal Carcinoid Tumors (2003) (102)
Analysis of Genomes and Transcriptomes of Hepatocellular Carcinomas Identifies Mutations and Gene Expression Changes in the Transforming Growth Factor-β Pathway. (2018) (99)
P14 methylation in human colon cancer is associated with microsatellite instability and wild-type p53. (2003) (99)
Pathologic complete response to neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma is associated with a better prognosis. (2012) (98)
Solid Pseudopapillary Neoplasm of the Pancreas: Clinicopathologic and Survival Analyses of 64 Cases From A Single Institution (2014) (95)
Disruption of transforming growth factor-β signaling through β-spectrin ELF leads to hepatocellular cancer through cyclin D1 activation (2007) (95)
Clinical and In vitro Studies of Imatinib in Advanced Carcinoid Tumors (2007) (93)
Expression of MAP4K4 Is Associated with Worse Prognosis in Patients with Stage II Pancreatic Ductal Adenocarcinoma (2008) (93)
Helicobacter pylori induces promoter methylation of E‐cadherin via interleukin‐1β activation of nitric oxide production in gastric cancer cells (2012) (91)
Frequent CpG Island Methylation in Serrated Adenomas of the Colorectum (2003) (90)
Disruption of transforming growth factor-beta signaling through beta-spectrin ELF leads to hepatocellular cancer through cyclin D1 activation. (2007) (89)
Genetic epidemiology of mutated K-rasproto-oncogene, altered suppressor genes, and microsatellite instability in colorectal adenomas (1999) (89)
Role of transforming growth factor β signaling and expansion of progenitor cells in regenerating liver (2010) (88)
Comparison of Epigenetic and Genetic Alterations in Mucinous Cystic Neoplasm and Serous Microcystic Adenoma of Pancreas (2003) (87)
Expression of Annexin A1 in Esophageal and Esophagogastric Junction Adenocarcinomas: Association with Poor Outcome (2006) (85)
Hepatitis B and C virus infection and the risk of biliary tract cancer: A population‐based study in China (2007) (84)
Comparison of genetic alterations in neuroendocrine tumors: frequent loss of chromosome 18 in ileal carcinoid tumors (2005) (84)
Genetic alterations in hepatocellular carcinomas: association between loss of chromosome 4q and p53 gene mutations (1999) (82)
Reduced Expression of Cytokeratin 20 in Colorectal Carcinomas With High Levels of Microsatellite Instability (2004) (82)
miR-21 Inhibition Reduces Liver Fibrosis and Prevents Tumor Development by Inducing Apoptosis of CD24+ Progenitor Cells. (2015) (81)
Cellular and molecular biology of biliary tract cancers. (2002) (78)
Validation of a Proposed Tumor Regression Grading Scheme for Pancreatic Ductal Adenocarcinoma After Neoadjuvant Therapy as a Prognostic Indicator for Survival (2016) (78)
Variants in inflammation genes and the risk of biliary tract cancers and stones: a population-based study in China. (2008) (77)
Serum lipid levels and the risk of biliary tract cancers and biliary stones: A population‐based study in China (2007) (76)
Chromosome 9p21 loss and p16 inactivation in primary sclerosing cholangitis-associated cholangiocarcinoma. (1999) (76)
Identification of cancer stem cells in human gastrointestinal carcinoid and neuroendocrine tumors. (2011) (76)
Post‐therapy pathologic stage and survival in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant chemoradiation (2012) (75)
Sinonasal adenocarcinoma: evidence for histogenetic divergence of the enteric and nonenteric phenotypes. (2003) (73)
Imaging features of fibrolamellar hepatocellular carcinoma. (2014) (73)
Radiation Therapy Oncology Group 0247: a randomized Phase II study of neoadjuvant capecitabine and irinotecan or capecitabine and oxaliplatin with concurrent radiotherapy for patients with locally advanced rectal cancer. (2012) (73)
Signet-Ring Cell or Mucinous Histology after Preoperative Chemoradiation and Survival in Patients with Esophageal or Esophagogastric Junction Adenocarcinoma (2005) (73)
Comparison of primary and metastatic malignant melanoma of the esophagus: clinicopathologic review of 10 cases. (2008) (72)
Genetic variation in the PNPLA3 gene and hepatocellular carcinoma in USA: Risk and prognosis prediction (2013) (71)
Suppression of Peutz-Jeghers Polyposis by Targeting Mammalian Target of Rapamycin Signaling (2008) (70)
Goblet cell carcinoid tumor, mixed goblet cell carcinoid-adenocarcinoma, and adenocarcinoma of the appendix: comparison of clinicopathologic features and prognosis. (2015) (69)
Estrogen Replacement Reduces Risk and Increases Survival Times of Women With Hepatocellular Carcinoma (2017) (67)
Natural language processing as an alternative to manual reporting of colonoscopy quality metrics. (2014) (66)
Complex Patterns of Altered MicroRNA Expression during the Adenoma-Adenocarcinoma Sequence for Microsatellite-Stable Colorectal Cancer (2011) (66)
Genetic analysis of sinonasal adenocarcinoma phenotypes: distinct alterations of histogenetic significance (2005) (66)
Prostaglandin-endoperoxide synthase 2 (PTGS2) gene polymorphisms and risk of biliary tract cancer and gallstones: a population-based study in Shanghai, China. (2006) (66)
Mutation of Lkb1 and p53 genes exert a cooperative effect on tumorigenesis. (2005) (66)
Molecular Characterization of Gallbladder Cancer using Somatic Mutation Profiling (2013) (65)
Genetic alterations and epithelial dysplasia in juvenile polyposis syndrome and sporadic juvenile polyps. (1997) (65)
Allelic alterations in well‐differentiated neuroendocrine tumors (carcinoid tumors) identified by genome‐wide single nucleotide polymorphism analysis and comparison with pancreatic endocrine tumors (2008) (65)
Histologic tumor involvement of superior mesenteric vein/portal vein predicts poor prognosis in patients with stage II pancreatic adenocarcinoma treated with neoadjuvant chemoradiation (2012) (64)
p53 overexpression and K-ras gene mutations in primary sclerosing cholangitis-associated biliary tract cancer. (2000) (63)
Lymphovascular invasion as a tool to further subclassify T1b esophageal adenocarcinoma (2008) (62)
Catalytic subunit of human telomerase reverse transcriptase is an independent predictor of survival in patients undergoing curative resection of hepatic colorectal metastases: a multicenter analysis. (2005) (60)
Molecular Biomarkers Correlate with Disease-Free Survival in Patients with Anal Canal Carcinoma Treated with Chemoradiation (2010) (58)
Outcome of EMR as an alternative to surgery in patients with complex colon polyps. (2016) (58)
The Development and Characterization of a Human Midgut Carcinoid Cell Line (2007) (57)
Overexpression of caspase-3 in hepatocellular carcinomas (2004) (56)
Prognostic Significance of New AJCC Tumor Stage in Patients With Pancreatic Ductal Adenocarcinoma Treated With Neoadjuvant Therapy (2017) (56)
Prognostic significance of tumor grading and staging in mammary carcinomas with neuroendocrine differentiation. (2011) (55)
Alterations of p16 and Prognosis in Biliary Tract Cancers from a Population-Based Study in China (2004) (53)
Varying malignant potential of appendiceal neuroendocrine tumors: Importance of histologic subtype (2013) (53)
Hypomethylation of long interspersed nuclear element-1 in hepatocellular carcinomas (2009) (51)
Comprehensive Genomic Profiling of Metastatic Squamous Cell Carcinoma of the Anal Canal (2017) (50)
Quantified pathologic response assessed as residual tumor burden is a predictor of recurrence‐free survival in patients with rectal cancer who undergo resection after neoadjuvant chemoradiotherapy (2013) (50)
Association between Helicobacter pylori infection and interleukin 1β polymorphism predispose to CpG island methylation in gastric cancer (2007) (50)
Selected base excision repair gene polymorphisms and susceptibility to biliary tract cancer and biliary stones: a population-based case-control study in China. (2007) (50)
Association of Aflatoxin and Gallbladder Cancer. (2017) (49)
Neuroendocrine Tumors of the Colon and Rectum: Prognostic Relevance and Comparative Performance of Current Staging Systems (2013) (49)
Metabolic syndrome and insulin resistance in relation to biliary tract cancer and stone risks: a population-based study in Shanghai, China (2011) (49)
Oesophageal hyperkeratosis: clinicopathological associations (2013) (49)
CEBS: a comprehensive annotated database of toxicological data (2016) (49)
Superior Mesenteric Artery Margin of Posttherapy Pancreaticoduodenectomy and Prognosis in Patients With Pancreatic Ductal Adenocarcinoma (2015) (49)
Desmoid tumor of the small bowel and the mesentery. (2004) (49)
Human telomerase reverse transcriptase (hTERT) and Ki-67 are better predictors of survival than established clinical indicators in patients undergoing curative hepatic resection for colorectal metastases (2006) (49)
Metastasis regulation by PPARD expression in cancer cells. (2017) (49)
Expansion of Hepatic and Hematopoietic Stem Cells Utilizing Mouse Embryonic Liver Explants (2001) (48)
Epigenetic and genetic alterations in duodenal carcinomas are distinct from biliary and ampullary carcinomas. (2003) (47)
Decreased Expression of Gene Cluster at Chromosome 1q21 Defines Molecular Subgroups of Chemoradiotherapy Response in Esophageal Cancers (2007) (47)
CpG island methylation in precursors of gastrointestinal malignancies. (2006) (46)
Overexpression of caspase-3 in hepatocellular carcinomas (2004) (46)
E-cadherin promoter hypermethylation induced by interleukin-1beta treatment or H. pylori infection in human gastric cancer cell lines. (2008) (46)
Effects of sex and racial/ethnic group on the pattern of gastric cancer localization (2002) (46)
Diabetes in relation to biliary tract cancer and stones: a population-based study in Shanghai, China (2010) (45)
Beta-catenin mutations in biliary tract cancers: a population-based study in China. (2001) (45)
Molecular Profiling of Hepatocellular Carcinoma Using Circulating Cell-Free DNA (2019) (45)
Tumor Invasion of Muscular Vessels Predicts Poor Prognosis in Patients With Pancreatic Ductal Adenocarcinoma Who Have Received Neoadjuvant Therapy and Pancreaticoduodenectomy (2012) (45)
Signet ring cells in esophageal adenocarcinoma predict poor response to preoperative chemoradiation. (2014) (45)
Critical interactions between TGF-β signaling/ELF, and E-cadherin/β-catenin mediated tumor suppression (2006) (45)
V‐CLIP: Integrating plasma vascular endothelial growth factor into a new scoring system to stratify patients with advanced hepatocellular carcinoma for clinical trials (2011) (44)
Aspirin Use and Risk of Biliary Tract Cancer: A Population-Based Study in Shanghai, China (2005) (44)
Differing DNA Methylation Patterns and Gene Mutation Frequencies in Colorectal Carcinomas from Middle Eastern Countries (2005) (44)
Characterization of interleukin-1β in Helicobacter pylori-induced gastric inflammation and DNA methylation in interleukin-1 receptor type 1 knockout (IL-1R1(-/-)) mice. (2013) (43)
Duplicated Muscularis Mucosae Invasion has Similar Risk of Lymph Node Metastasis and Recurrence-free Survival as Intramucosal Esophageal Adenocarcinoma (2011) (42)
Body size and the risk of biliary tract cancer: a population-based study in China (2008) (42)
The number and ratio of positive lymph nodes affect pancreatic cancer patient survival after neoadjuvant therapy and pancreaticoduodenectomy (2016) (42)
High-Grade Neuroendocrine Colorectal Carcinomas: A Retrospective Study of 100 Patients. (2015) (42)
Invasive ductal adenocarcinoma arising from pancreatic heterotopia in rectum: case report and review of literature. (2010) (41)
Outcome of gastric cancer patients after successful gastrectomy (2006) (41)
Detection rates of premalignant polyps during screening colonoscopy: time to revise quality standards? (2015) (41)
Assessment of BRAF V600E Status in Colorectal Carcinoma: Tissue-Specific Discordances between Immunohistochemistry and Sequencing (2015) (41)
Pharmacodynamic analysis of target inhibition and endothelial cell death in tumors treated with the vascular endothelial growth factor receptor antagonists SU5416 or SU6668. (2005) (41)
Prognostic value of response after upfront therapy for acute GVHD (2012) (41)
High-level Microsatellite Instability in Appendiceal Carcinomas (2013) (41)
Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trial. (2022) (41)
Genetic alterations in cancer knowledge system: analysis of gene mutations in mouse and human liver and lung tumors. (2006) (41)
SOX9: a useful marker for pancreatic ductal lineage of pancreatic neoplasms. (2014) (40)
NCCN Clinical Practice Guidelines Occult primary. (2011) (40)
Vitamin D Deficiency Promotes Liver Tumor Growth in Transforming Growth Factor-β/Smad3-Deficient Mice Through Wnt and Toll-like Receptor 7 Pathway Modulation (2016) (39)
Prognostic Significance of Tumor-Infiltrating Lymphocytes in Patients With Pancreatic Ductal Adenocarcinoma Treated With Neoadjuvant Chemotherapy (2017) (39)
Final results of a randomized, open label, perioperative phase II study evaluating nivolumab alone or nivolumab plus ipilimumab in patients with resectable HCC. (2019) (39)
DEAR1 is a chromosome 1p35 tumor suppressor and master regulator of TGF-β-driven epithelial-mesenchymal transition. (2013) (38)
Polymorphisms of Genes in the Lipid Metabolism Pathway and Risk of Biliary Tract Cancers and Stones: A Population-Based Case-Control Study in Shanghai, China (2008) (38)
Cholesterol metabolism gene polymorphisms and the risk of biliary tract cancers and stones: a population-based case-control study in Shanghai, China. (2011) (37)
High Levels of Nucleolar Expression of Nucleolin Are Associated with Better Prognosis in Patients with Stage II Pancreatic Ductal Adenocarcinoma (2010) (37)
Biallelic inactivation of the APC gene is associated with hepatocellular carcinoma in familial adenomatous polyposis coli (2001) (36)
Evaluating clinical and prognostic implications of Glypican-3 in hepatocellular carcinoma (2016) (36)
HuR Suppresses Fas Expression and Correlates with Patient Outcome in Liver Cancer (2015) (36)
Progesterone receptor and PTEN expression predict survival in patients with low- and intermediate-grade pancreatic neuroendocrine tumors. (2014) (36)
Biliary tract cancer and stones in relation to chronic liver conditions: A population‐based study in Shanghai, China (2007) (35)
Allelic alterations in pancreatic endocrine tumors identified by genome-wide single nucleotide polymorphism analysis. (2007) (35)
Epigenetic Silencing of β-Spectrin, a TGF-β Signaling/Scaffolding Protein in a Human Cancer Stem Cell Disorder (2010) (35)
Chemical effects in biological systems--data dictionary (CEBS-DD): a compendium of terms for the capture and integration of biological study design description, conventional phenotypes, and 'omics data. (2005) (34)
Primary colonic-type adenocarcinoma of the base of the tongue: a previously unreported phenotype. (2009) (33)
I-CLIP: Improved Stratification of Advanced Hepatocellular Carcinoma Patients by Integrating Plasma IGF-1 into CLIP Score (2011) (33)
Reproductive factors and risks of biliary tract cancers and stones: a population-based study in Shanghai, China (2010) (33)
Polymorphism of genes related to insulin sensitivity and the risk of biliary tract cancer and biliary stone: a population-based case–control study in Shanghai, China (2008) (32)
Variants in hormone-related genes and the risk of biliary tract cancers and stones: a population-based study in China. (2009) (32)
Efficacy endpoints of radiation therapy group protocol 0247: a randomized, phase 2 study of neoadjuvant radiation therapy plus concurrent capecitabine and irinotecan or capecitabine and oxaliplatin for patients with locally advanced rectal cancer. (2015) (31)
Loss of cooperative function of transforming growth factor‐β signaling proteins, smad3 with embryonic liver fodrin, a β‐spectrin, in primary biliary cirrhosis (2004) (31)
Correlation of Staining for LKB1 and COX-2 in Hamartomatous Polyps and Carcinomas from Patients with Peutz–Jeghers Syndrome (2003) (31)
Telomere dysfunction activates YAP1 to drive tissue inflammation (2020) (30)
Inactivation of ELF/TGF-beta signaling in human gastrointestinal cancer. (2005) (30)
Inactivation of ELF/TGF-β signaling in human gastrointestinal cancer (2005) (30)
Pancreatic intraepithelial neoplasia and histological changes in non‐neoplastic pancreas associated with neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma (2013) (30)
Genetic determinants of serum lipid levels in Chinese subjects: a population-based study in Shanghai, China (2009) (30)
Mucosal Colonization by Metastatic Carcinoma in the Gastrointestinal Tract: A Potential Mimic of Primary Neoplasia (2011) (29)
Systemic therapy for unresectable, mixed hepatocellular-cholangiocarcinoma: treatment of a rare malignancy. (2017) (29)
Tea drinking and the risk of biliary tract cancers and biliary stones: A population‐based case–control study in Shanghai, China (2006) (29)
Polymorphisms of estrogen receptors and risk of biliary tract cancers and gallstones: a population-based study in Shanghai, China. (2010) (29)
Clinicopathologic Features Associated With Human Papillomavirus/p16 in Patients With Metastatic Squamous Cell Carcinoma of the Anal Canal. (2015) (28)
Loss of chromosome 18q and DPC4 (Smad4) mutations in appendiceal adenocarcinomas (2004) (28)
The significance of neuroendocrine differentiation in adenocarcinoma of the esophagus and esophagogastric junction after preoperative chemoradiation (2006) (28)
Immunotherapy response evaluation with magnetic resonance elastography (MRE) in advanced HCC (2019) (28)
TGF-β/β2-spectrin/CTCF-regulated tumor suppression in human stem cell disorder Beckwith-Wiedemann syndrome. (2016) (28)
Neuroendocrine and mucinous differentiation in signet ring cell carcinoma of the stomach: evidence for a common cell of origin in composite tumors. (2011) (27)
CYP17 MspA1 polymorphism and risk of biliary tract cancers and gallstones: A population‐based study in Shanghai, China (2006) (27)
Differential expression of retinoic acid receptors and p53 protein in normal, premalignant, and malignant esophageal tissues (2001) (27)
Phase I study of the anti-IGF1R antibody cixutumumab with everolimus and octreotide in advanced well-differentiated neuroendocrine tumors. (2015) (27)
Association of inflammatory and other immune markers with gallbladder cancer: Results from two independent case-control studies. (2016) (26)
Intraluminal polypoid metastasis of renal cell carcinoma in gallbladder mimicking gallbladder polyp. (2010) (26)
Diet and biliary tract cancer risk in Shanghai, China (2017) (25)
RTOG 0247: A randomized phase II study of neoadjuvant capecitabine and irinotecan versus capecitabine and oxaliplatin with concurrent radiation therapy for locally advanced rectal cancer (2008) (25)
Variants of DNA Repair Genes and the Risk of Biliary Tract Cancers and Stones: A Population-Based Study in China (2008) (24)
Effect of timing of metastasis/disease recurrence and histologic differentiation on survival of patients with advanced gastric cancer (2007) (23)
Interleukin-1β increases the risk of gastric cancer through induction of aberrant DNA methylation in a mouse model. (2016) (23)
Intrabiliary Growth of Liver Metastases (2013) (23)
Reduced expression of argininosuccinate synthetase 1 has a negative prognostic impact in patients with pancreatic ductal adenocarcinoma (2017) (23)
Occult primary, version 3.2014; Featured updates to the NCCN guidelines (2014) (22)
Development and Validation of Insulin-like Growth Factor-1 Score to Assess Hepatic Reserve in Hepatocellular Carcinoma (2014) (22)
A Metallomic Approach to Assess Associations of Serum Metal Levels With Gallstones and Gallbladder Cancer (2020) (21)
Low-grade neuroendocrine tumors arising in intestinal adenomas: evidence for alterations in the adenomatous polyposis coli/β-catenin pathway. (2014) (20)
Loss of phosphatase and tensin homolog expression is associated with recurrence and poor prognosis in patients with pancreatic ductal adenocarcinoma. (2013) (20)
Clinicopathologic features and prognosis of duodenal adenocarcinoma and comparison with ampullary and pancreatic ductal adenocarcinoma. (2013) (20)
Gene methylation in non-neoplastic mucosa of gastric cancer: age or Helicobacter pylori related? (2003) (20)
Validation of a Preclinical Model of Diethylnitrosamine-Induced Hepatic Neoplasia in Yucatan Miniature Pigs (2016) (20)
Expression of Estrogen-Induced Genes and Estrogen Receptor &bgr; in Pancreatic Neuroendocrine Tumors: Implications for Targeted Therapy (2014) (20)
Aberrant expression of p53, p21, cyclin D1, and Bcl2 and their clinicopathological correlation in ampullary adenocarcinoma. (2014) (19)
Loss of the transforming growth factor‐β effector β2‐Spectrin promotes genomic instability (2017) (19)
An Inverse Correlation between Interleukin-6 and Select Gene Promoter Methylation in Patients with Gastric Cancer (2007) (19)
Occult primary. (2008) (18)
Hepatic endometriosis mimicking metastatic disease: a case report and review of the literature. (2010) (18)
Comparison of dynamic contrast-enhanced magnetic resonance imaging and contrast-enhanced ultrasound for evaluation of the effects of sorafenib in a rat model of hepatocellular carcinoma. (2019) (18)
Overexpression and prevalence of molecular markers in patients with cancer of unknown primary (CUP) (2005) (17)
Mutational Profiles Reveal an Aberrant TGF-β-CEA Regulated Pathway in Colon Adenomas (2016) (17)
Variations in DNA repair genomic alterations and tumor mutation burden in biliary tract cancer (BTC) subtypes. (2018) (17)
Frequent loss of heterozygosity of chromosome 1q in esophageal adenocarcinoma (2009) (17)
Origin and role of hepatic myofibroblasts in hepatocellular carcinoma (2020) (17)
Inflammatory gene variants and the risk of biliary tract cancers and stones: a population-based study in China (2012) (16)
The expression of PTEN is associated with improved prognosis in patients with ampullary adenocarcinoma after pancreaticoduodenectomy. (2013) (16)
Occult primary, version 3.2014. (2014) (15)
Value of endoscopic ultrasound staging in conjunction with the evaluation of lymphovascular invasion in identifying low‐risk esophageal carcinoma (2008) (15)
Association of circulating inflammation proteins and gallstone disease (2018) (15)
Medical history and the risk of biliary tract cancers in Shanghai, China: implications for a role of inflammation (2011) (15)
Telomere dysfunction instigates inflammation in inflammatory bowel disease (2021) (15)
Circulating inflammatory proteins and gallbladder cancer: Potential for risk stratification to improve prioritization for cholecystectomy in high-risk regions. (2018) (14)
Utilization of cytology smears improves success rates of RNA‐based next‐generation sequencing gene fusion assays for clinically relevant predictive biomarkers (2020) (14)
Stability of E‐cadherin methylation status in gastric mucosa associated with histology changes (2006) (14)
Solid pseudopapillary neoplasm of the pancreas with prominent atypical multinucleated giant tumour cells (2013) (14)
Integrative molecular characterization of gallbladder cancer reveals microenvironment-associated subtypes. (2020) (13)
Clinical and prognostic significance of circulating levels of angiopoietin-1 and angiopoietin-2 in hepatocellular carcinoma (2018) (13)
A phase II open-label study of OSI-774 (NSC 718781) in unresectable hepatocellular carcinoma (2005) (12)
Prognostic model for patient survival in primary anorectal mucosal melanoma: stage at presentation determines relevance of histopathologic features (2019) (12)
Chronic typhoid infection and the risk of biliary tract cancer and stones in Shanghai, China (2011) (12)
Expression of MAP 4 K 4 Is Associated withWorse Prognosis in Patients with Stage II Pancreatic Ductal Adenocarcinoma (2008) (11)
The TGx‐28.65 biomarker online application for analysis of transcriptomics data to identify DNA damage‐inducing chemicals in human cell cultures (2017) (11)
Chemoradiation for High-grade Neuroendocrine Carcinoma of the Rectum and Anal Canal (2017) (11)
Circulating Levels of Inflammatory Proteins and Survival in Patients with Gallbladder Cancer (2018) (11)
Targeting the E3 Ubiquitin Ligase PJA1 Enhances Tumor-Suppressing TGFβ Signaling (2020) (11)
Rhabdomyosarcoma of the Long Bone in an Adult (1994) (11)
Somatic deletions of the polyA tract in the 3' untranslated region of epidermal growth factor receptor are common in microsatellite instability-high endometrial and colorectal carcinomas. (2012) (10)
Lipopolysaccharide-pathway proteins are associated with gallbladder cancer among adults in Shanghai, China with mediation by systemic inflammation. (2016) (10)
Significance of T1a and T1b Carcinoma Arising in Mucinous Cystic Neoplasm of Pancreas (2018) (10)
Expression of Annexin A1in Esophageal and Esophagogastric Junction Adenocarcinomas: Associationwith Poor Outcome (2006) (10)
RNA sequencing-based analysis of gallbladder cancer reveals the importance of the liver X receptor and lipid metabolism in gallbladder cancer (2016) (10)
Anti-phosphorylated histone H3 expression in Barrett's esophagus, low-grade dysplasia, high-grade dysplasia, and adenocarcinoma (2009) (9)
Validation of an IGF-CTP scoring system for assessing hepatic reserve in egyptian patients with hepatocellular carcinoma (2015) (9)
Alcohol, stem cells and cancer (2017) (9)
Effect of sarcopenia on systemic targeted therapy response in patients with advanced hepatocellular carcinoma (2020) (9)
Loss of the TGF-β Effector β2SP Promotes Genomic Instability. (2016) (9)
Should we routinely expose recurrent laryngeal nerve(s) during thyroid surgery? (2013) (8)
Expansion of hepatic and hematopoietic stem cells utilizing mouse embryonic liver explants. (2001) (8)
Loss of DPC4/SMAD4 expression in primary gastrointestinal neuroendocrine tumors is associated with cancer‐related death after resection (2017) (8)
Expression of Epithelial-Mesenchymal Transition Markers in Treated Pancreatic Ductal Adenocarcinoma. (2019) (8)
Androgen Receptor CAG Repeat Length and Risk of Biliary Tract Cancer and Stones (2010) (8)
Development of a murine colonoscopic polypectomy model (with videos). (2016) (8)
Histologic Grade 1 Is Associated With Increased Nonrelapsed Mortality in Lower Gastrointestinal Graft Versus Host Disease (2017) (8)
Nonalcoholic steatohepatitis-related hepatocellular carcinoma: is there a role for the androgen receptor pathway? (2017) (7)
Expression and clinical significance of epidermal growth factor receptor and insulin-like growth factor receptor 1 in patients with ampullary adenocarcinoma. (2015) (7)
Dietary N‐Nitroso Compounds and Risk of Hepatocellular Carcinoma: A USA‐Based Study (2021) (7)
Generation of a mouse model of T-cell lymphoma based on chronic LPS challenge and TGF-β signaling disruption (2014) (7)
Metastatic adult granulosa cell tumor mimicking a benign pancreatic cyst. (2010) (7)
HepatoScore‐14: Measures of Biological Heterogeneity Significantly Improve Prediction of Hepatocellular Carcinoma Risk (2020) (7)
Cap-fitted endoscopic mucosal resection of ≥ 20 mm colon flat lesions followed by argon plasma coagulation results in a low adenoma recurrence rate (2020) (7)
Quality of endoscopy reporting at index colonoscopy significantly impacts outcome of subsequent EMR in patients with > 20 mm colon polyps (2019) (6)
Down-regulation of CYP1A1 expression in breast cancer. (2012) (6)
POLIO VACCINATION; KNOWLEDGE, ATTITUDE, AND PRACTICE IN DISTRICT ABBOTTABAD, KHYBER PAKHTUNKHWA, PAKISTAN. (2014) (6)
Dietary Patterns and Hepatocellular Carcinoma Risk among US Adults (2021) (6)
Reversal of E-cadherin promoter hypermethylation status after helicobacter pylori eradication (2004) (6)
[A survey on the diagnosis and treatment of biliary tract cancers in Shanghai]. (2005) (5)
Impact of Integrating Insulin-Like Growth Factor 1 Levels into Model for End-Stage Liver Disease Score for Survival Prediction in Hepatocellular Carcinoma Patients (2020) (5)
Tchou, J.C. et al. GSTP1 CpG island DNA hypermethylation in hepatocellular carcinoma. Int. J. Oncol. 16, 663−676 (2000) (5)
Gastric cancer in the remnant stomach after pancreaticoduodenectomy: A case series (2019) (4)
Disruption of Growth Hormone Receptor Signaling Abrogates Hepatocellular Carcinoma Development (2022) (4)
Clinicopathological correlation of radiologic measurement of post-therapy tumor size and tumor volume for pancreatic ductal adenocarcinoma. (2020) (4)
Factors Impacting Clinically Relevant RNA Fusion Assays Using Next-Generation Sequencing. (2021) (4)
[Tea consumption and risk of biliary tract cancers and gallstone disease: a population-based case-control study in Shanghai, China]. (2005) (3)
Gallbladder carcinoma presenting as a pelvic mass with elevated serum testosterone: a case report. (2009) (3)
Insulin-like growth factor 1/Child-Turcotte-Pugh composite score as a predictor of treatment outcomes in patients with advanced hepatocellular carcinoma treated with sorafenib (2021) (3)
Loss of Menin Expression by Immunohistochemistry in Pancreatic Neuroendocrine Tumors: Comparison Between Primary and Metastatic Tumors (2019) (3)
Natural History of T1N0M0 Hepatocellular Carcinoma: Large-Scale Study in the United States (2017) (3)
Loss of PTEN Expression Is Associated with Recurrence and Poor Prognosis in Patients with Pancreatic Ductal Adenocarcinoma (2013) (3)
Using MRI to non-invasively and accurately quantify preoperative hepatic steatosis. (2017) (3)
Blockade of growth hormone receptor signaling by using pegvisomant: A functional therapeutic strategy in hepatocellular carcinoma (2022) (3)
Association of dietary fat intake and hepatocellular carcinoma among US adults (2021) (2)
Identification of unique somatic mutations with functional relevance through genetic characterization of gallbladder cancer (GB ca). (2013) (2)
Efficacy Endpoints of RTOG 0247: A Randomized Phase II Study of Neoadjuvant Radiation Therapy Plus Concurrent Capecitabine and Irinotecan or Capecitabine and Oxaliplatin for Patients with Locally Advanced Rectal Cancer (2015) (2)
CEA as a blood-based biomarker in anal cancer (2021) (2)
Occult primary cancer clinical practice guidelines. (2005) (2)
Pancreatic ductal adenocarcinoma: neoadjuvant therapies and pathology (2014) (2)
Efficacy endpoints of RTOG 0247: A randomized phase II study of neoadjuvant capecitabine (C) and irinotecan (I) or C and oxaliplatin (O) with concurrent radiation therapy (RT) for locally advanced rectal cancer. (2011) (2)
DIABETIC FOOT ULCER; SEQUELAE (2016) (2)
ALVARADO SCORE; (2013) (2)
Prognostic Significance of Serum Insulin-Like Growth Factor-1 in Hepatocellular Cancer Patients: A Validation Study (2020) (2)
BAP1 mutation-associated cholangiocarcinoma: An aggressive disease. (2015) (2)
Inhibition of apoptosis in familial adenomatous polyposis (FAP) and its modification by sulindac (1995) (2)
TGF-b/b2-spectrin/CTCF-regulated tumor suppression in human stem cell disorder Beckwith-Wiedemann syndrome (2019) (2)
Erratum: Expression of Epidermal Growth Factor Receptor In Esophageal and Esophagogastric Junction Adeno-carcinomas: Association With Poor Outcome (Cancer (2007) 109 (658-667)) (2009) (2)
HISTOPATHOLOGIC DIAGNOSIS OF CHRONIC GRAFT VERSUS HOST DISEASE 2014 NIH Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-Versus-Host Disease: II. Pathology Working Group Report (2006) (1)
T1468: Neuroendocrine Tumors of Gastrointestinal Tract and the Pancreas: Diagnostic Modalities, Accuracy, and Outcomes (2010) (1)
Loss of SMAD4 and effect on overall survival in resected gastrointestinal neuroendocrine tumors. (2014) (1)
Association of human papillomavirus with unique clinicopathologic features in patients with metastatic squamous cell carcinoma of the anal canal. (2014) (1)
Effect of p53 overexpression and K-ras gene mutations on survival in patients with primary sclerosing cholangitis-associated cholangiocarcinoma (1998) (1)
Inflammatory gene variants and the risk of biliary tract cancers and stones: a population-based study in China (2012) (1)
Integrated Pathologic Score Effectively Stratifies Patients With Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Therapy and Pancreaticoduodenectomy (2023) (1)
ASGE oral abstract166 Natural Language Processing (NLP) As an Alternative to Manual Reporting of Colonoscopy Quality Metrics (2014) (1)
A phase I study of the anti-IGF-1R monoclonal antibody (MoAb), IMC-A12 (I), and everolimus (E) in well-differentiated neuroendocrine tumors (WD NET). (2014) (1)
GRP78 expression and prognostic significance in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant therapy versus surgery first. (2021) (1)
Molecular profiling by circulating tumor DNA (ctDNA) and benefit from anti-PD-1 in HCC. (2019) (1)
CEA as a pharmacodynamic biomarker for metastatic anal cancer. (2018) (1)
Challenges in next generation sequencing analysis of somatic mutations in transplant patients. (2018) (1)
Plasma GH as a diagnostic and prognostic biomarker in HCC without cirrhosis. (2019) (1)
Abstract 1547: Expression of epithelial-to-mesenchymal transition markers (EMT) in treated pancreatic duct adenocarcinoma (2018) (1)
1062 Outcome of Referral to an Endoscopic Mucosal Resection Center As an Alternative to Surgery in Patients With Large and Flat Colon Tumors (2015) (1)
Immune checkpoint blockade (ICB) response evaluation with MRI/MR elastography (MRE) in surgical and nonsurgical patients with HCC. (2020) (1)
Body mass index (BMI), waist to hip ratio (WHR) and risk of biliary tract cancers: A population —based case—control study in Shanghai, China (2005) (1)
Comprehensive Genomic Pro fi ling of Metastatic Squamous Cell Carcinoma of the Anal Canal (2017) (1)
Down-Regulation of CYP 1 A 1 Expression in Breast Cancer (2012) (1)
Activation of hedgehog pathway in neuroendocrine tumors. (2012) (1)
Outcome of Endoscopic Mucosal Resection As an Alternative to Surgery in Patients with Complex Colon Polyps (2016) (1)
Clinical and prognostic significance of serum levels of fatty acid binding proteins in hepatocellular carcinoma (HCC). (2019) (0)
Abstract 3921: Generation of a T-cell lymphoma mouse model based on chronic LPS challenge and TGF-β signaling disruption (2014) (0)
Colorectal high-grade neuroendocrine carcinoma: A single institution experience. (2014) (0)
Sa1928 Whole Genome Analysis of Colon Adenomas Reveals Novel Prognostic and Therapeutic Targets (2014) (0)
Erratum: Associations of Ki-ras proto-oncogene mutation and p53 gene overexpression in sporadic colorectal adenomas with demographic and clinicopathologic characteristics (Cancer Epidemiology Biomarkers and Prevention (August 2006) 15 (1443-1450)) (2006) (0)
Hepatocellular Carcinoma (2019) (0)
Diagnosis and management for gallbladder carcinoma among Shanghai citizens (2005) (0)
42 The role of tissue stiffness in predicting the immunotherapy response in hepatocellular carcinoma (2021) (0)
Disappearing of promoter methylation of E-cadherin gene in gastric mucosa after Helicobacter pylori eradication (2004) (0)
A population-based case-control study on serum lipids in relation to biliary tract cancer and cholelithiasis in Shanghai, China (2006) (0)
1047 - Targeting E3 Ligase PJA1 Through TGF-β Pathway in Hepatocellular Carcinoma (2018) (0)
Next-generation sequencing yields promising targets in advanced cholangiocarcinoma (CCA). (2014) (0)
Title Promoter methylation of E-cadherin gene in gastric mucosa associated with Helicobacter pylori infection and in gastric cancer (2003) (0)
CpG ISLAND METHYLATION and CHROMOSOME 1P LOSS IN ABERRANT CRYPT FOCI (2001) (0)
DIABETIC FOOT ULCER (2016) (0)
The Houston Society of Clinical Pathologists 55th Annual Spring Symposium, April 2014. (2015) (0)
Sa1411 Adenoma Detection Rate (ADR) and Serrated Adenoma Detection Rate (Sdr) During Screening Colonoscopy With and Without a Personal Cancer History (Pch) in a Tertiary Referral Cancer Center (2014) (0)
A negative correlation between IL-6 and DNA methylation in patients with gastric cancer (2006) (0)
Author Correction: Circulating Levels of Inflammatory Proteins and Survival in Patients with Gallbladder Cancer (2020) (0)
Abstract 2873: Imaging tumor heterogeneity after multikinase inhibitor therapy in rat hepatocellular carcinoma (2017) (0)
Metastatic lung adenocarcinoma mimicking Richter transformation in a patient with chronic lymphocytic leukemia. (2020) (0)
Abstract 4106: Methods for the development of carcinoid cell lines and carcinoid associated fibroblasts (2010) (0)
Mo1435 – Pathway Specific Functional Biomarkers for the Early Detection of Liver Cancer (2019) (0)
Su1611 Outcome of a Protocol Driven Endoscopic Resection of Patients With Large Colon Polyps (>20 MM) Results in Low Complications and Recurrence (2017) (0)
Prospective study of a 10-gene molecular assay to predict tissue of origin in patients with carcinoma of unknown primary (CUP) (2016) (0)
Abstract 5330: Targeting hepatocellular carcinoma through TGF-β pathway E3 ligases (2017) (0)
Abstract 67: Genomic and mutational profiling of human colon adenomas reveals early driver mutations and a TGF-β-CEA regulated profile (2015) (0)
Prognosticators for Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant FOLFIRINOX or Gemcitabine/Nab-Paclitaxel Therapy and Pancreatectomy (2023) (0)
Postoperative unsuspected gallbladder carcinoma (2005) (0)
Cellular Interactions of TGF-β Pathway Members and Epigenetic Regulators of Liver and Gastrointestinal Cancers (2017) (0)
Epigenetic abnormalities of gastric cancer (2012) (0)
Abstract 248: Vitamin D deficiency promotes hepatocellular carcinoma tumor growth in TGF-β impaired mice by Smad3 heterozygous deletion (2014) (0)
OF NEOADJUVANT CAPECITABINE AND IRINOTECAN OR CAPECITABINE AND OXALIPLATIN WITH CONCURRENT RADIOTHERAPY FOR PATIENTS WITH LOCALLYADVANCED RECTAL CANCER (2012) (0)
Identification of Serum Biomarkers for Biliary Tract Cancers by a Proteomic Approach Based on Time-of-Flight Mass Spectrometry (2010) (0)
Abstract LB-157: Association of aflatoxin and gallbladder cancer in Shanghai (2017) (0)
Radiation Therapy for High-Grade Neuroendocrine Carcinoma of the Rectum and Anal Canal (2014) (0)
Abstract B132: Next generation sequencing yields promising targets in advanced cholangiocarcinoma (CCA). (2013) (0)
SF-101-3 Allelic Alterations in Pancreatic Endocrine Tumors by Genome : Wide Single Nucleotide Polymorphism Analysis (2007) (0)
Occult primary: Clinical practice guidelines in oncology (2008) (0)
TGF beta signaling by SMAD2/3 and ELF spectrins results in bile duct formation and is disrupted in primary biliary cirrhosis (2000) (0)
Body Mass Index IBMI ) ,Waist to Hip Ratio ( WHR ) and Risk of Biliary Tract Cancers:A Population-based (2012) (0)
Abstract 5199: Primary culture of human midgut carcinoid cell lines and isolation of a putative carcinoid stem cell population (2011) (0)
Abstract 3900: Genomic landscape of human cancer reveals dysregulated TGF-β signaling with prognostic significance (2015) (0)
Erratum: Overexpression of caspase-3 in hepatocellular carcinomas (Modern Pathology (2004) 17 (861-867) doi:10.1038/modpathol.3800146 (2004) (0)
Abstract 4560: A new IGF-1-integrated Child-Pugh score to risk-stratify patients with hepatocellular carcinoma (2012) (0)
Circulating Levels of Inflammatory Proteins and Survival in Patients with Gallbladder Cancer (2018) (0)
Comparison of microRNA (MiRNA) expression profiles between opisthorchis viverrini-associated cholangiocarcinoma (OV-CCA) and non-opisthorchis viverrini-associated cholangiocarcinoma (non-OV CCA). (2013) (0)
Helicobacter pylori infection, interleukin 1 beta polymorphism andpredisposition to gastric cancer through the CpG island methylation pathway (2006) (0)
Pancreas and Biliary Tree (2015) (0)
Abstract 3441: Associations between lipopolysaccharide (LPS) and LPS pathway biomarkers and gallbladder cancer are modulated by markers of systemic inflammation (2016) (0)
Abstract IA004: Targeting STAT3 with TTI-101, an oral small molecule, to prevent colorectal and hepatocellular cancer (2022) (0)
Pathology and Immunohistochemistry of Hereditary Colorectal Cancer (2011) (0)
Intestinal Gastric Cancer: Diagnosis: History, clinical and histopathology (2009) (0)
Mo1643 Diets With Subnormal Supplementation of Vitamin D Regimen Promote Hepatocellular Carcinoma Tumor Growth in TGF-β Impaired Mice With SMAD3 Heterozygous Deletion (2014) (0)
LKB1 GENE TISSUE SPECIFIC KNOCKOUT MOUSE MODEL FOR PANCREATIC CANCER (2005) (0)
Abstract 4703: Genome & exome analysis of early colon cancers reveals new targets (2014) (0)
Haploinsufficiency of CDK4 prevents hepatocarcinogenesis in mice deficient in ELF, a mediator of TGF-beta signaling (2007) (0)
Su1954 Esophageal Squamous Dysplasia – Clinical Associations and Follow-up (2013) (0)
Abstract 6136: Generation and characterization of colorectal cancer cell lines from the Buffalo rat (2020) (0)
Abstract 3156: Pathway Specific Functional Biomarkers for the Early Detection of Liver Cancer (2019) (0)
P084: Microsatellite instability and high tumor mutational burden is concordant with loss of mismatch repair proteins (2023) (0)
Polymorphism of genes in the lipid metabolism pathway and the risk of biliary tract cancers: a population-based study in Shanghai, China (2005) (0)
IGF-Child-Pugh score as a predictor of treatment outcome in Child-Pugh A, advanced hepatocellular carcinoma patients undergoing sorafenib therapy. (2019) (0)
Gene profiling validation for cancer classification using known primary carcinoma samples (2007) (0)
Family History of Cancer in Patients with Colorectal Cancer Association of the CpG Island Methylator Phenotype with Updated Version (2003) (0)
Analyzing Abnormal Liver Enzymes in a Patient With Renal Cell Carcinoma: 1260 (2017) (0)
Gastrointestinal Pathology (2015) (0)
Abstract C171: Novel therapeutic strategies targeting the hedgehog signaling pathway and mTOR pathway in biliary tract cancer (BTC). (2013) (0)
Sa1412 Adenoma Detection Rate & Sessile Serrated Adenoma Detection Rate Trends With Increasing Age: a Study Using a Natural Language Processing Computer Program (2014) (0)
Molecular Pathology of Colon and Small Bowel Cancers: Sporadic Type (2013) (0)
Abstract 2334: Disruption of TGF-β-regulated CTCF suppression of telomerase links a human stem cell disorder to tumorigenesis (2015) (0)
Abstract 3594: The TGF-β effector β2SP depletion abrogates DNA damage repair (2016) (0)
Contents Vol. 80, 2011 (2011) (0)
Abstract A11: Prognostic model for disease-specific survival in anorectal melanoma (2020) (0)
Correction: critical interactions between TGF-β signaling/ELF, and E-cadherin/β-catenin mediated tumor suppression (2021) (0)
Su1024 – The Role of E3 Ligase Pja1 in Proliferation and Tumorigenesis of Hepatocellular Carcinoma (2019) (0)
3:54 PM Abstract No. 196 Molecularly targeted photothermal ablation enhances the effect of anti-PD1 therapy in a mouse model of hepatocellular carcinoma (2020) (0)
Benign glandular downgrowth in gastric neuroendocrine neoplasms: a potential mimic of composite tumour (2014) (0)
Plasma growth hormone is a potential biomarker of response to atezolizumab and bevacizumab in advanced hepatocellular carcinoma patients (2022) (0)
Abstract 21: Optimization of dosing regimens of sulindac in combination with erlotinib for small intestine and colorectal cancer prevention (2020) (0)
532 A TGF-β-CTCF Regulated Pathway Suppresses Stem Cell Associated Tumor Progression (2015) (0)
Title: Molecular profiling of hepatocellular carcinoma using circulating cell-free DNA Short Title: Cell-free DNA in hepatocellular carcinoma Authors: (2019) (0)
Sa1914 The Genomic Landscape of Human Colon Adenomas Reveals Early Driver Mutations and a TGF-β-CEA Regulated Profile (2015) (0)
Expression and clinical significance of epidermal growth factor receptor and insulin-like growth factor receptor 1 in patients with (2015) (0)
International validation of an IGF-CTP scoring system for assessing hepatic reserve in hepatocellular carcinoma. (2015) (0)
Sa1954 Vitamin D Deficiency Promotes Hepatocellular Cancer via Regulating TLR7 in the Context of Loss of TGF-β/Smad3 (2015) (0)
Stage at presentation to determine associations between histologic parameters of primary tumor and disease specific survival (DSS) in anorectal melanoma (AM). (2018) (0)
SAT-451-Gallbladder disease in the absence of cirrhosis is a significant risk factor for hepatocellular carcinoma (2019) (0)
CpG Island methylation and the pathogenesis of hyperplastic polyposis (2001) (0)
Leukemic Infiltration of Colon in a Case of Diarrhea Post Hematopoietic Cell Transplantation (HCT). (2017) (0)
Contemporay assessment of extrahepatic bile duct strictures (2003) (0)
Recent Advances in Molecular Classification and Prognosis of Colorectal Cancer (2004) (0)
Abstract 5046: Gallbladder disease and the risk of hepatocellular carcinoma: US case-control study (2019) (0)
DifferingDNAMethylation Patterns andGeneMutation Frequencies in Colorectal Carcinomas fromMiddle Eastern Countries (2005) (0)
Histologic Confirmation for Patients Presenting with Gastrointestinal Graft Versus Host Disease: How to Interpret Histologic Grade 1 (Does It Matter)? (2015) (0)
Abstract 892: Vitamin D deficiency regulates TLR7 to promote hepatocellular cancer in TGF-β/Smad3 heterozygous mice (2015) (0)
TGF-b / b 2-spectrin / CTCF-regulated tumor suppression in human stem cell disorder Beckwith-Wiedemann syndrome (2019) (0)
Su1288 High Synchronous Polyp Burden in Patients With ≥ 1 CM Colon Polyps (2012) (0)
Abstract No. 609 Development of a transplantable colon adenocarcinoma model in the Buffalo rat (2019) (0)
Abstract 839: Novel polypectomy system in a preclinical model of colon cancer (2016) (0)
Clinical Testing for Mismatch Repair in Neoplasms Using Multiple Laboratory Methods (2022) (0)
Recent Advances in Histopathology of Gastrointestinal Cancers: Prognostic and Therapeutic Assessment of Colorectal Cancers (2005) (0)
High level of nucleolar expression of catalytic subunit of human telomerase reverse transcriptase (hTERT) is associated with better prognosis in patients with esophageal and esophagogastric junction adenocarcinomas (2007) (0)
Number of lymph nodes with metastasis predict survival in patients with esophageal or esophagogastric junction adenocarcinoma treated with preoperative chemoradiation (2005) (0)
Gastrointestinal Acuity Score (GAS): A Comprehensive Risk Score Incorporating Histologic Grade and Clinical Factors to Predict Need for Second Line Therapy, Non-Relapse Mortality, and Overall Survival in Lower Gastrointestinal Graft Vs. Host Disease (2015) (0)
Author Correction: Circulating Levels of Inflammatory Proteins and Survival in Patients with Gallbladder Cancer (2020) (0)
Tu1624 Dysregulated TGF-β Signaling Leads to Genomic Instability and Liver Cancer (2016) (0)
Gastrointestinal Pathology (2015) (0)
Mast Cell Concentrations Correlate with Hepatic Fibrosis in Cancer Patients (2020) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Asif Zaman Rashid?

Asif Zaman Rashid is affiliated with the following schools:

MD Anderson Cancer Center
Johns Hopkins University